ArticleGut2025

Clinical results of an HBV-specific T-cell receptor-T-cell therapy (SCG101) in patients with HBV-related hepatocellular carcinoma treated in an investigator-initiated, interventional trial.

Xiang'an Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.